← Open Payments lookup

GRAIG SANDERS: Open Payments

NPI 1932177912 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,936 in 107 payments from 16 companies in 2025. Trend: 2023 $1,590 · 2024 $1,793 · 2025 $1,936

Food & beverage: $1,936
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.42$514
Novartis Pharmaceuticals Corporation14$230
Amgen Inc.9$190
AstraZeneca Pharmaceuticals LP8$157
Merck Sharp & Dohme LLC6$142
Esperion Therapeutics, Inc.5$134
Novo Nordisk Inc4$110
Actelion Pharmaceuticals US, Inc.4$106
Alnylam Pharmaceuticals Inc.4$101
Bayer Healthcare Pharmaceuticals Inc.4$83

Products named: CAMZYOS, LEQVIO, Repatha, NEXLETOL, ELIQUIS, VERQUVO, Wegovy, OPSUMIT.

Industry payments across CT — which companies pay providers there.